Zynex Inc. Stock price OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 227M | Sales 2025 * | 290M | Capitalization | 398M |
---|---|---|---|---|---|
Net income 2024 * | 17M | Net income 2025 * | 32M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | 33.11M | Net cash position 2025 * | 11.06M | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
25.6
x | P/E ratio 2025 * |
13.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.01% |
Latest transcript on Zynex Inc.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Daniel Moorhead
DFI | Director of Finance/CFO | 51 | 17-06-04 |
Anna Lucsok
COO | Chief Operating Officer | 38 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 18-01-09 | |
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Michael D. Cress
BRD | Director/Board Member | 66 | 18-01-09 |
1st Jan change | Capi. | |
---|---|---|
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |